Heparin anticoagulation in patients admitted to hospital with COVID‐19

The summary explains the current picture while awaiting full peer-reviewed results, and emphasises that any decisions regarding anticoagulation for individual patients should incorporate a risk assessment for bleeding as well as additional thrombotic risk factors.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.